Göbel W, Lieb W E, Ho A, Sergott R C, Farhoumand R, Grehn F
Universitäts-Augenklinik Mainz.
Ophthalmologe. 1994 Feb;91(1):26-30.
Color Doppler imaging is a new noninvasive technique that allows the measurement of flow velocity in small orbital vessels (both arteries and veins). We compared 59 eyes with proliferative, 47 eyes with nonproliferative and 24 eyes with preproliferative diabetic fundus changes with a control group of non-diabetic patients. The central retinal artery, short ciliary artery and ophthalmic artery of each patient were examined. The systolic, diastolic and mean velocity was obtained for each vessel. Differences between the groups were most prominent in the central retinal artery. The perfusion velocity was significantly lower (P < 0.01) in proliferative eyes (Vsyst 5.7 +/- 1.9 cm/s) than in the control group (Vsyst 9.4 +/- 1.4 cm/s) or the nonproliferative eyes (Vsyst 8.3 +/- 1.9 cm/s). In the preproliferative group the velocity distribution varied widely. Consequently, no statistically significant difference could be deduced in relation to either the control group or the group with proliferative diabetic changes. In the ophthalmic artery and ciliary artery no group showed significant differences from normal. Our measurements indicate a definite correlation between the severity of diabetic retinopathy and a decreased flow velocity, particularly in the central retinal artery. Thus, color Doppler imaging may help to identify those diabetic patients who are at high risk of developing severe diabetic retinopathy so that early photocoagulation treatment can be initiated.
彩色多普勒成像技术是一项新的非侵入性技术,可用于测量眼眶内小血管(包括动脉和静脉)中的血流速度。我们将59例患有增殖性糖尿病眼底病变的患者、47例患有非增殖性糖尿病眼底病变的患者以及24例患有增殖前期糖尿病眼底病变的患者与一组非糖尿病患者进行了对照比较。对每位患者的视网膜中央动脉、睫状短动脉和眼动脉进行了检查,测量了每条血管的收缩期、舒张期和平均血流速度。各组之间的差异在视网膜中央动脉最为显著。增殖性病变眼的灌注速度(收缩期速度5.7±1.9cm/s)显著低于对照组(收缩期速度9.4±1.4cm/s)或非增殖性病变眼(收缩期速度8.3±1.9cm/s)(P<0.01)。增殖前期病变组的血流速度分布差异较大,因此,与对照组或增殖性糖尿病病变组相比,未发现有统计学意义的差异。眼动脉和睫状动脉各组与正常组相比均无显著差异。我们的测量结果表明,糖尿病视网膜病变的严重程度与血流速度降低之间存在明确的相关性,尤其是在视网膜中央动脉。因此,彩色多普勒成像有助于识别那些有发生严重糖尿病视网膜病变高风险的糖尿病患者,以便尽早开始进行光凝治疗。